Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 901–1,000 of 1,001
Wu, S., Lai, Y., He, Z., Zhou, Y., Chen, S., Mingming, D., Zhou, J., Lin, Q., & Chi, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120811 · Cited by 28
“analyzed patients treated for breast cancer between 1958 and 2001 and found that the probability of ischemic heart disease started to increase after several years post radiotherapy, and such increase would last for at least 20 years [23].”
BackgroundIntegrated Rehabilitation for Breast Cancer Survivors
Cheville, A. L., McLaughlin, S. A., Haddad, T. C., Lyons, K. D., Newman, R. M., & Ruddy, K. J. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001017 · Cited by 31
“Left-sided radiation also contributes to the increased risk of ischemic heart disease and cardiogenic death in survivors of breast cancer.(101) Data regarding the impact of exercise training during doxorubicin and trastuzumab treatment on immediate measures of cardiotoxicity have been mixed.”
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Kaiser, A., Eley, J. G., Onyeuku, N. E., Rice, S. R., Wright, C. C., McGovern, N. E., Sank, M., Zhu, M., Vujašković, Ž., Simone, C. B., et al. (2019) · Journal of Visualized Experiments · doi:10.3791/58372 · Cited by 32
Vittrup, A. S., Kirchheiner, K., Fokdal, L. U., Bentzen, S. M., Nout, R. A., Pötter, R., & Tanderup, K. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.08.040 · Cited by 29
Hierarchical clustering applied to automatic atlas based segmentation of 25 cardiac sub-structures
Maffei, N., Fiorini, L., Aluisio, G., D’Angelo, E., Ferrazza, P., Vanoni, V., Lohr, F., Meduri, B., & Guidi, G. (2019) · Physica Medica · doi:10.1016/j.ejmp.2019.12.001 · Cited by 28
Ibrahim, E. H., Baruah, D., Croisille, P., Stojanovska, J., Rubenstein, J., Frei, A. C., Schlaak, R. A., Lin, C., Pipke, J. L., Lemke, A., et al. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.12.006 · Cited by 28
“Radiationinduced cardiac dysfunction can occur months to years following cardiac RT exposure, and cardiac sequelae can include a number of clinical manifestations, including ischemic heart disease, fibrosis, arrhythmias, cardiomyopathy, valvular abnormalities, and/or pericarditis (1,2).”
BackgroundPreliminary pre-clinical studies on the side effects of breast cancer treatment
Salata, C., de Almeida, C. E., Ferreira-Machado, S. C., Barroso, R. C., Nogueira, L. P., Mantuano, A., Pickler, A., Mota, C. L., & de Andrade, C. B. V. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1919782 · Cited by 28
“Darby et al. (Darby et al. 2013) and Sardaro et al. (Sardaro et al. 2012) reported a 7.4% and 4% risk of cardiac disease for each gray (Gy) mean heart dose, respectively.”
BackgroundInfluentialProne position versus supine position in postoperative radiotherapy for breast cancer
Lai, J., Zhong, F., Deng, J., Hu, S., Shen, R., Luo, H., & Luo, Y. (2021) · Medicine · doi:10.1097/md.0000000000026000 · Cited by 28
Milo, M. L. H., Nyeng, T. B., Lorenzen, E. L., Hoffmann, L., Møller, D. S., & Offersen, B. V. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1967445 · Cited by 28
“In recent years, the awareness of radiation-associated cardiac toxicity, particularly coronary artery disease, has increased [3,4].”
BackgroundPeters, G. W., Gao, S. J., Knowlton, C. A., Zhang, A., Evans, S. B., Higgins, S. A., Wilson, L. D., Saltmarsh, N., Picone, M., & Moran, M. S. (2021) · Practical Radiation Oncology · doi:10.1016/j.prro.2021.08.010 · Cited by 28
Kim, K., Chung, S. Y., Oh, C., Cho, I., Kim, K. H., Byun, H. K., Yoon, H. I., Oh, J., & Chang, J. S. (2022) · The Breast · doi:10.1016/j.breast.2022.07.003 · Cited by 28
“first reported the dose-response relationship between radiation dose and ischemic heart disease risk in Danish and Swedish breast cancer patients [23].”
BackgroundTissue Reactions and Mechanism in Cardiovascular Diseases Induced by Radiation
Liu, X., & Zhou, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314786 · Cited by 34
“Furthermore, the ischemia region is linked to the radiotherapy site and dosage [62].”
BackgroundOnwudiwe, N. C., Kwok, Y., Onukwugha, E., Sorkin, J. D., Zuckerman, I. H., Shaya, F. T., & Mullins, C. D. (2014) · Cancer Medicine · doi:10.1002/cam4.283 · Cited by 29
“have been reported in patients with longer time since exposure [32].”
BackgroundEssers, M., Osman, S. O. S., Hol, S., Donkers, T., & Poortmans, P. M. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.887226 · Cited by 28
Picot, J., Copley, V. R., Colquitt, J. L., Kalita, N., Hartwell, D., & Bryant, J. (2015) · Health Technology Assessment · doi:10.3310/hta19690 · Cited by 34
Cardio-oncology: Concepts and practice
Cubbon, R. M., & Lyon, A. R. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.01.022 · Cited by 28
“Indeed, other studies have failed to demonstrate this association,(21) although the most recently published large cohort follow-up data continue to show a dose-dependent relationship between radiotherapy and increased cardiovascular risk.(22)”
ResultEffect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up
Wu, S. P., Tam, M. M., Vega, R. B. M., Perez, C. A., & Gerber, N. K. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.018 · Cited by 31
Management of Heart Failure in Cancer Patients and Cancer Survivors
Finet, J. E. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2016.12.004 · Cited by 28
“It has recently been shown that the cumulative cardiac radiation dose is proportionally correlated with the rate of major acute coronary events; the ensuing increased mortality risk is intensified by additional coexistent cardiovascular risk factors.(45) Radiotherapy-induced cardiomyopathy is commonly accompanied by i…”
BackgroundJensen, C. A., Abramova, T. M., Frengen, J., & Lund, J. (2017) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12137 · Cited by 31
“The best approach would be to minimize any dose to the heart without compromising the dose to the target.(30) Our clinical study assessed the interfraction setup variability with an in-house developed DIBH system, and also evaluated the doses to OAR and target with the system.”
BackgroundAl‐Hammadi, N., Caparrotti, P., Naim, C., Hayes, J., Benson, K. R., Vasic, A., Al-Abdulla, H. H., Hammoud, R. W., Divakar, S. R., & Petrič, P. (2018) · Radiology and Oncology · doi:10.1515/raon-2018-0008 · Cited by 28
Metformin reduces radiation-induced cardiac toxicity risk in patients having breast cancer.
Yu, J., Hsieh, M., Qin, L., Zhang, J., & Wu, S. (2019) · PubMed · Cited by 33
Cai, G., Li, C., Yu, J., & Meng, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00153 · Cited by 29
“With a long-term follow-up, increases in probabilities of cardiac toxicities with ionizing radiation exposure to the heart have been observed in long-term survivors of lymphoma (1, 2) and breast cancer (3, 4).”
BackgroundPasalic, D., Strom, E. A., Allen, P. K., Williamson, T. D., Poenisch, F., Amos, R. A., Woodward, W. A., Stauder, M. C., Shaitelman, S. F., Smith, B. D., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.09.009 · Cited by 28
Incidence of hypothyroidism after treatment for breast cancer—a Danish matched cohort study
Falstie‐Jensen, A. M., Öztürk, B., Kjærsgaard, A., Lorenzen, E. L., Jensen, J. D., Reinertsen, K. V., Dekkers, O. M., Ewertz, M., & Cronin-Fenton, D. P. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01337-z · Cited by 28
Self-citationKiserud, C. E., Dahl, A. A., Loge, J. H., & Fosså, S. D. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-40187-9_8 · Cited by 28
Tembhekar, A. R., Wright, C. L., & Daly, M. E. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.12.007 · Cited by 28
Xue, J., Jiang, Z., Qi, F., Lv, S., Zhang, S., Wang, T., & Zhang, X. (2014) · Journal of Breast Cancer · doi:10.4048/jbc.2014.17.4.363 · Cited by 27
“Long-term cardiac follow-up is therefore essential in these patients [18].”
BackgroundManagement of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective
Giza, D. E., Marmagkiolis, K., Mouhayar, E., Durand, J., & Iliescu, C. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0862-x · Cited by 28
Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
Herskovic, A., Wu, X., Christos, P. J., & Nagar, H. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.02.006 · Cited by 27
“Clinical Breast Cancer October 2018 critique of that argument has been that the long-term data are from patients treated with older RT techniques that exposed the heart to a higher radiation dose than modern techniques.(16) Additionally, our study did not demonstrate a survival detriment to receiving adjuvant RT, whic…”
MethodArsene-Henry, A., Foy, J., Robilliard, M., Xu, H., Bazire, L., Peurien, D., Poortmans, P. M., Fourquet, A., & Kirova, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.25286 · Cited by 27
“These complex volumes explain the higher doses to heart in comparison with the general recommendations [6].”
BackgroundRisk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study
Hamood, R., Hamood, H., Merhasin, I., & Keinan‐Boker, L. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.10.009 · Cited by 27
Pasquier, D., Tinier, F. L., Bennadji, R., Jouin, A., Horn, S., Escande, A., Tresch, E., Chauvet, M. P., Mailliez, A., Crop, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39469-8 · Cited by 27
Chan, S. T., Ruan, D., Shaverdian, N., Raghavan, G., Cao, M., & Lee, P. P. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.10.010 · Cited by 27
Yeh, H.-P., Huang, Y., Wang, L., Shueng, P., Tien, H., Chang, C., Chou, S.-F., & Hsieh, C.-H. (2020) · British Journal of Radiology · doi:10.1259/bjr.20190792 · Cited by 27
Complex Clinical Decision-Making Process of Re-Irradiation
Armstrong, S., & Hoskin, P. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.07.023 · Cited by 27
Jafari, F., Safaei, A. M., Hosseini, L., Asadian, S., Kamangar, T. M., Zadehbagheri, F., & Rezaeian, N. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10028-y · Cited by 27
Matthews, A., Hinton, S. P., Stanway, S. J., Lyon, A. R., Smeeth, L. L., Bhaskaran, K., & Lund, J. L. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7629 · Cited by 30
Misra, S., Mishra, A., Lal, P., Srivastava, R., Verma, M., Kumar, S. K. S., & Das, K. J. M. (2021) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2020.12.004 · Cited by 28
Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction
Trivedi, S. J., Tang, S., Byth, K., Stefani, L. D., Lo, Q., Otton, J. M., Jameson, M., Tran, D. D., Batumalai, V., Holloway, L. C., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019476 · Cited by 27
“We demonstrate that (1) radiotherapy dose is highest in the anterior wall followed by the anteroseptal and anterolateral LV walls, and lowest in the inferolateral and inferior walls, (2) radiotherapy dose received increases from basal to apical regions for all LV walls, (3) the greatest reductions in myocardial strain…”
Speers, C. W., Murthy, V. L., Walker, E., Glide‐Hurst, C. K., Marsh, R., Tang, M., Morris, E. L., Schipper, M. J., Weinberg, R. L., Gits, H. C., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.08.039 · Cited by 28
“Studies such as the one by Darby et al suggest cardiac toxicity might occur even with low doses of radiation, basing their modeling of the dose-response relationship on comparisons of modeled patients treated with older treatment techniques.(4) The doses were only estimated, however, using a single CT scan of a woman…”
BackgroundZhao, A. T., Larbi, M., Miller, K., O’Neill, S. C., & Jayasekera, J. C. (2021) · The Breast · doi:10.1016/j.breast.2021.12.003 · Cited by 27
“The fi nal tool we evaluated was the ‘ Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer ’ [63].”
MethodPreparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy
Meng, C., Fan, L., Wang, X., Wang, Y., Li, Y., Pang, S., Lv, S., & Zhang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3820591 · Cited by 30
“4% when the radiation dose increases by 1Gy [73].”
Honaryar, M. K., Allodji, R. S., Ferrières, J., Panh, L., Locquet, M., Jimenez, G., Lapeyre, M., Camilleri, J., Broggio, D., de Vathaire, F., et al. (2022) · Cancers · doi:10.3390/cancers14235724 · Cited by 27
Parijs, H. V., Reynders, T., Heuninckx, K., Verellen, D., Storme, G. A., & Ridder, M. D. (2014) · BioMed Research International · doi:10.1155/2014/827475 · Cited by 27
The Global Challenge of Reducing Breast Cancer Mortality
Burton, R. C., & Bell, R. J. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0315 · Cited by 27
Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer
Cuzick, J. M. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv392 · Cited by 27
Lawler, G., & Leech, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11394 · Cited by 27
Mille, M. M., Jung, J. W., Lee, C., Kuzmin, G. A., & Lee, C. (2018) · Journal of Radiological Protection · doi:10.1088/1361-6498/aabd4f · Cited by 27
Proton Therapy for Primary Breast Cancer
Hug, E. B. (2018) · Breast Care · doi:10.1159/000489893 · Cited by 27
Vikström, J., Hjelstuen, M. H. B., Wasbø, E., Mjaaland, I., & Dybvik, K. I. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1497294 · Cited by 27
“Gradually, the knowledge of the risks associated with irradiation of the heart has increased [2,3] and new techniques for sparing heart tissue have emerged.”
BackgroundLa relación bidireccional entre el cáncer y la ateroesclerosis
Raposeiras‐Roubín, S., & Cordero, A. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.12.011 · Cited by 28
Re-irradiation in locally recurrent lung cancer patients
Schlampp, I., Rieber, J., Adeberg, S., Bozorgmehr, F., Heußel, C. P., Steins, M. B., Kappes, J., Hoffmann, H., Welzel, T., Debus, J., et al. (2019) · Strahlentherapie und Onkologie · doi:10.1007/s00066-019-01457-2 · Cited by 27
Chałubińska‐Fendler, J., Graczyk, Ł., Piotrowski, G., Wyka, K., Nowicka, Z., Tomasik, B., Fijuth, J., Kozono, D., & Fendler, W. M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.04.002 · Cited by 27
Mutter, R. W., Jethwa, K. R., Tseung, H. S. W. C., Wick, S. M., Kahila, M. M. H., Viehman, J. K., Shumway, D. A., Corbin, K. S., Park, S. S., Remmes, N. B., et al. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.08.011 · Cited by 27
Mayr, N. A., Borm, K. J., Kalet, A. M., Wootton, L. S., Chadderdon, A. L., Combs, S. E., Wang, W., Cao, N., Lo, S. S.-M., Sandison, G. A., et al. (2020) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000241 · Cited by 30
“4% for each 1 Gy increase in the average radiation dose to the heart (mean heart dose).(9) A recent worldwide systematic review of heart doses in left breast radiotherapy reported”
BackgroundMoignier, A., Broggio, D., Derreumaux, S., Baf, F. E., Mandin, A., Girinsky, T., Paul, J., Chea, M., Jenny, C., Franck, D., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.055 · Cited by 27
“Improvements in radiation therapy (RT) have increased patient life span and highlighted late effects, making cardiovascular disease a major concern (1-3), in particular after left-sided breast RT.”
Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer
Goldman, U. B., Svane, G., Anderson, M. P., Wennberg, B., & Lind, P. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.934967 · Cited by 27
Mulliez, T., de Velde, J. V., Veldeman, L., Gersem, W. D., Vercauteren, T., Speleers, B., Degen, H., Wouters, J., Hoof, T. V., Greveling, A. V., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.09.030 · Cited by 29
Brouwers, P. J. A. M., Lustberg, T., Borger, J. H., van Baardwijk, A. A. W., Jager, J. J., Murrer, L. H. P., Nijsten, S. M. J. J. G., Reymen, B. J. T., van Loon, J., & Boersma, L. J. (2014) · Practical Radiation Oncology · doi:10.1016/j.prro.2014.10.005 · Cited by 26
Arjmandi, M. K., Moslemi, D., Zarrini, A. S., Gorji, M. E., Mosapour, A., Haghighi, A. H., Halalkhor, S., Bijani, A., & Parsian, H. (2016) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2015.12.009 · Cited by 26
Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery
Kuerer, H. M., Cordeiro, P. G., & Mutter, R. W. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175342 · Cited by 26
Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors
Chang, J. S., Shin, J., Park, E., & Kim, Y. B. (2018) · The Breast · doi:10.1016/j.breast.2018.11.003 · Cited by 28
van Loevezijn, A. A., Bartels, S. A. L., van Duijnhoven, F. H., Heemsbergen, W. D., Bosma, S. C. J., Elkhuizen, P. H. M., Donswijk, M. L., Rutgers, E. J. T., Oldenburg, H. S. A., Peeters, M.-J. T. F. D. V., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-7058-5 · Cited by 26
Grendarova, P., Roumeliotis, M. B., Quirk, S., Lesiuk, M., Craighead, P. S., Liu, H.-W., Pinilla, J., Wilson, J. F., Bignell, K., Phan, T., et al. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.04.002 · Cited by 26
Plasma metabolite biomarkers predictive of radiation induced cardiotoxicity
Unger, K. R., Li, Y., Yeh, C., Barac, A., Srichai, M. B., Ballew, E., Girgis, M. J., Jayatilake, M. M., Sridharan, V., Boerma, M., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.018 · Cited by 26
“The risk of cardiac events increases in a dose-dependent manner [21].”
BackgroundKirova, Y., Tallet, A. R., Aznar, M. C., Loap, P., Bouali, A., & Bourgier, C. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.07.001 · Cited by 26
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
Månsson‐Broberg, A., Geisler, J., TUOHINEN, S. S., Skyttä, T., Hrafnkelsdóttir, Þ. J., Nielsen, K. M., Hedayati, E., Omland, T., Offersen, B. V., Lyon, A. R., et al. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00486-8 · Cited by 28
Tagami, T., Almahariq, M. F., Balanescu, D. V., Quinn, T. J., Dilworth, J. T., Franklin, B. A., & Bilolikar, A. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.038 · Cited by 27
Tramm, T., Vinter, H., Vahl, P., Özcan, D., Alsner, J., & Overgaard, J. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1989629 · Cited by 27
“Not all BC patients gain benefit from RT and some patients may only suffer the risk of RT associated early and late sideeffects, including ischemic heart disease [17,18] and secondary cancer [19].”
BackgroundLong-Term Risk of Death From Heart Disease Among Breast Cancer Patients
Agha, A., Wang, X., Wang, M., Lehrer, E. J., Horn, S. R., Rosenberg, J., Trifiletti, D. M., Diaz, R., Louie, A. V., & Zaorsky, N. G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.784409 · Cited by 26
“6) increase in the rate of major coronary events per Gray of mean heart dose (17).”
BackgroundPreclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers
Dreyfuss, A. D., Velalopoulou, A. P., Avgousti, H., Bell, B. I., & Verginadis, I. I. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920867 · Cited by 29
Civil, Y. A., Jonker, L. W., Koerkamp, M. P. M. G., Duvivier, K. M., de Vries, R., Oei, A. L., Slotman, B. J., van der Velde, S., & van den Bongard, H. J. G. D. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13233-9 · Cited by 26
Balgobind, B. V., Visser, J., Grehn, M., Knap, M. M., Ruysscher, D. D., Levis, M., Alcántara, P., Boda‐Heggemann, J., Both, M., Cozzi, S., et al. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109949 · Cited by 26
Carpenter, D. J., Patel, P., Niedzwiecki, D., Dillon, M., Diaz, A. K., Kumar, A., Mowery, Y. M., Crowell, K., D’Anna, R. K., Wu, Q., et al. (2023) · Cancer · doi:10.1002/cncr.35089 · Cited by 32
Tan, W., Xu, L., Wang, X., Qiu, D., Han, G., & Hu, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s52101 · Cited by 31
“and morbidity.(7,8) Theoretically, both the microvascular and macrovascular radiation-related cardiac damage could combine to cause ischemic heart disease.”
BackgroundHepel, J. T., Hiatt, J. R., Sha, S. J., Leonard, K. L., Graves, T. A., Wiggins, D. L., Mastras, D., Pittier, A., & Wazer, D. E. (2014) · Brachytherapy · doi:10.1016/j.brachy.2014.05.014 · Cited by 26
“These organs are potentially at risk for long-term complications and can result in treatment-related morbidity and mortality (1, 5).”
BackgroundMast, M. E., Heijenbrok, M. W., Petoukhova, A., Scholten, A. N., Schreur, J. H. M., & Struikmans, H. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.012 · Cited by 28
Huang, Y.-H. J., Harrison, A., Sarkar, V., Rassiah-Szegedi, P., Zhao, H., Szegedi, M., Huang, L., Wilson, B. D., Gaffney, D. K., & Salter, B. J. (2016) · Advances in Radiation Oncology · doi:10.1016/j.adro.2016.04.002 · Cited by 26
“Our results correlate well with Darby et al’s recent study, which used symptomatic cardiac disease as the evaluation parameter.(29) Darby looked into patients with invasive breast cancer with EBRT history who experienced major coronary events (ie, diagnosis of myocardial infraction, coronary revascularization, or deat…”
MethodResultCoronary artery calcium in breast cancer survivors after radiation therapy
Takx, R. A. P., Vliegenthart, R., Schoepf, U. J., Pilz, L. R., Schoenberg, S. O., Morris, P. B., Henzler, T., & Apfaltrer, P. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1119-x · Cited by 27
“In addition, a population-based case-control study [12] found a linear increase in major coronary event rate per gray to the heart, independent of preexisting cardiac risk factors.”
BackgroundInfluentialSeawright, J. W., Samman, Y., Sridharan, V., Mao, X. W., Cao, M., Singh, P., Melnyk, S., Koturbash, I., Nelson, G. A., Hauer‐Jensen, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180594 · Cited by 27
Ödén, J., Toma-Daşu, I., Eriksson, K., Flejmer, A., & Daşu, A. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1348625 · Cited by 26
“Moreover, as it exists a concern of cardiopulmonary toxicity in long-term survivors [14], the potential effect of the variable RBE should be investigated.”
BackgroundBaselet, B., Azimzadeh, O., Erbeldinger, N., Bakshi, M. V., Dettmering, T., Janssen, A., Ktitareva, S., Lowe, D., Michaux, A., Quintens, R., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00570 · Cited by 28
“One of the known consequences of conventional low LET radiotherapy is an increased risk of cardiovascular diseases (CVD), especially when the heart is located within the radiation field (Darby et al., 2013; Aleman et al., 2014).”
BackgroundXu, Y., Wang, J., Hu, Z., Tian, Y., Ma, P., Li, S., Dai, J., & Wang, S. (2018) · Medical dosimetry · doi:10.1016/j.meddos.2018.09.004 · Cited by 26
Curigliano, G., de Azambuja, E., Lenihan, D. J., Calabró, M. G., Cardinale, D. M., & Cipolla, C. M. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0773 · Cited by 26
Testolin, A., Ciccarelli, S., Vidano, G., Avitabile, R., Dusi, F., & Alongi, F. (2019) · British Journal of Radiology · doi:10.1259/bjr.20190150 · Cited by 26
Zeng, Z., Du, H., Xiong, L., Zeng, X.-L., Zhang, P., Cai, J., Huang, L., & Liu, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117342 · Cited by 26
Cheng, H.-W., Chang, C.-C., Shiau, A., Wang, M.-H., & Tsai, J.-T. (2020) · Medical dosimetry · doi:10.1016/j.meddos.2020.01.006 · Cited by 28
DEGRO practical guidelines for radiotherapy of breast cancer V
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO), Budach, W., Matuschek, C., Bölke, E., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Piroth, M. D., et al. (2015) · Strahlentherapie und Onkologie · doi:10.1007/s00066-015-0843-1 · Cited by 26
Cardiovascular Health during and after Cancer Therapy
Ruddy, K. J., Patel, S. R., Higgins, A. S., Armenian, S. H., & Herrmann, J. (2020) · Cancers · doi:10.3390/cancers12123737 · Cited by 28
“Preventing radiation-induced heart disease is largely dependent on exposing the cardiac tissue to the lowest effective dose of radiation, as cardiotoxicity increases linearly with radiation dose (with no clear safe threshold) [7].”
BackgroundSalvestrini, V., Iorio, G. C., Borghetti, P., Felice, F. D., Greco, C., Nardone, V., Fiorentino, A., Gregucci, F., & Desideri, I. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03875-1 · Cited by 26
“As expected, evidence suggested that the cardiac avoidance in breast RT can provide a real decrease in clinical manifestations of cardiac toxicity (Darby et al. 2013; Clarke et al. 2005).”
BackgroundBartlett, F. R., Yarnold, J. R., Donovan, E. M., Evans, P., Locke, I., & Kirby, A. M. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.09.002 · Cited by 29
“Increased awareness of late cardiac toxicity coupled with improvements in radiotherapy techniques has helped to drive down the dose of radiation received by cardiac structures [5], but recent work suggests that themean heart dose (Gy) would need to be reduced to zero to eliminate the risk of late cardiac effects altog…”
BackgroundBooth, C. M., & Tannock, I. F. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5023 · Cited by 29
Marano, J., Kissick, M. W., Underwood, T. S. A., Laub, S., Lis, M., Schreuder, A. N., Kreydick, B., & Pankuch, M. (2023) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.14129 · Cited by 26
Huang, Y., Lin, J., Chen, W., Shia, B., & Wu, S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036411 · Cited by 28
“13 3,5–9 Despite recent advances in radiotherapy techniques aimed at minimizing cardiac irradiation, complete elimination of cardiotoxicity risk remains elusive.”
Schönecker, S., Angelini, L., Gaasch, A., Zinn, A., Konnerth, D., Heinz, C., Xiong, Y., Unger, K., Landry, G., Meattini, I., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103993 · Cited by 25
Targeted-theranostic nanoparticles induce anti-tumor immune response in lung cancer
Muradova, Z., Carmès, L., Virani, N. A., Rossetti, F., Guthier, R., Yasmin‐Karim, S., Lavelle, M. T., Morris, T., Guidelli, É. J., Isikawa, M. M., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03542-4 · Cited by 29
Proton Therapy for Breast Cancer: Getting to the Heart of the Matter
MacDonald, S. M. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.035 · Cited by 25
Emaus, M. J., Išgum, I., van Velzen, S. G. M., van den Bongard, H. J. G. D., Gernaat, S. A. M., Leßmann, N., Sattler, M. G. A., Teske, A. J., Penninkhof, J. J., Meijer, H. J. M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028752 · Cited by 27
Cardiotoxicity of breast cancer radiotherapy – overview of current results
Soumarová, R., & Rušinová, L. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.12.008 · Cited by 25
Lee, H.-H., Chen, C., Luo, K., Chuang, H., Huang, C., Cheng, Y.-K., Chen, F., Kuo, S.-H., & Huang, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61403-6 · Cited by 25
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.